SEC Form 4 · accession 0000792977-19-000045
AMAG PHARMACEUTICALS INC. · AMAG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elizabeth Scott Bolgiano
Officer — Chief Human Resources Officer
Period of report
Mar 1, 2019
Accepted (ET)
Mar 5, 2019 · 6:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000792977
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 1, 2019 | F | 696 | $14.76 | D | 70,778 | D | |
| Common StockF2 | Mar 2, 2019 | F | 931 | $14.76 | D | 69,847 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 2,001 restricted stock units on March 1, 2019.
- F2Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 2,999 restricted stock units on March 2, 2019.